Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress
Maria Marchetti, Lionel Resnick, Edna Gamliel et al. · 2009
Read Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress by Maria Marchetti, Lionel Resnick, Edna Gamliel et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005804.txt.
Description
Maria Marchetti and co-authors reported in 2009 that a common anti-inflammatory drug makes cancer cells easier to kill under oxidative stress. Sulindac, an approved NSAID, blocks enzymes that make prostaglandins. It has long drawn interest for preventing colon polyps and cancer.
Under stress from reactive oxygen, sulindac-treated cancer cells died more readily in the team's work. That pairing could matter for therapy: stress the cell, then remove its shield. The drug's long safety record makes such ideas quicker to test in people. The study adds a mechanism to an old drug's anticancer reputation.
Catalog record
| CREATOR | Maria Marchetti, Lionel Resnick, Edna Gamliel et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005804